JP2005513419A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005513419A5 JP2005513419A5 JP2003541863A JP2003541863A JP2005513419A5 JP 2005513419 A5 JP2005513419 A5 JP 2005513419A5 JP 2003541863 A JP2003541863 A JP 2003541863A JP 2003541863 A JP2003541863 A JP 2003541863A JP 2005513419 A5 JP2005513419 A5 JP 2005513419A5
- Authority
- JP
- Japan
- Prior art keywords
- pth
- pharmaceutical composition
- level
- agonist
- antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/002,818 US6524788B1 (en) | 2001-11-02 | 2001-11-02 | Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism |
| US10/286,465 US7056655B2 (en) | 2001-11-02 | 2002-11-01 | Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism |
| PCT/US2002/035516 WO2003039572A1 (en) | 2001-11-02 | 2002-11-04 | Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005513419A JP2005513419A (ja) | 2005-05-12 |
| JP2005513419A5 true JP2005513419A5 (https=) | 2006-01-12 |
Family
ID=26670921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003541863A Pending JP2005513419A (ja) | 2001-11-02 | 2002-11-04 | 続発性上皮小体機能亢進症を有する腎性患者における上皮小体ホルモンの治療的抑制をモニタリングおよび誘導するための方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US7056655B2 (https=) |
| EP (1) | EP1448217A4 (https=) |
| JP (1) | JP2005513419A (https=) |
| CA (1) | CA2465862A1 (https=) |
| WO (1) | WO2003039572A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6689566B1 (en) | 1999-01-14 | 2004-02-10 | Scantibodies Laboratory, Inc. | Methods, kits, and antibodies for detecting parathyroid hormone |
| US7820393B2 (en) * | 1999-01-14 | 2010-10-26 | Scantibodies Laboratory, Inc. | Methods, kits and antibodies for detecting parathyroid hormone |
| US6838264B2 (en) * | 2000-12-05 | 2005-01-04 | Immutopics, Inc. | Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84 |
| WO2007047327A2 (en) * | 2005-10-12 | 2007-04-26 | Proventiv Therapeutics, Llc | Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency |
| SI3095447T1 (sl) | 2006-02-03 | 2022-02-28 | Opko Renal, Llc | Zdravljenje pomanjkanja vitamina D s 25-hidroksivitaminom D2 in 25-hidroksivitaminom D3 |
| HUE037309T2 (hu) * | 2006-06-21 | 2018-08-28 | Opko Ireland Global Holdings Ltd | Terápia D-vitamin telítési szer alkalmazásával és D-vitamin hormon helyettesítõ szer |
| PT3335712T (pt) | 2007-04-25 | 2025-10-23 | Opko Renal Llc | Método de tratamento e prevenção seguro e eficaz do hiperparatiroidismo secundário na doença renal crónica |
| DK2148684T3 (da) | 2007-04-25 | 2013-04-22 | Cytochroma Inc | Fremgangsmåde til behandling af vitamin D-insufficiens og -deficiens |
| US8592401B2 (en) | 2007-04-25 | 2013-11-26 | Proventiv Therapeutics, Llc | Methods and compounds for vitamin D therapy |
| PL2148661T3 (pl) | 2007-04-25 | 2013-07-31 | Cytochroma Inc | Doustne kompozycje o kontrolowanym uwalnianiu zawierające związek będący witaminą D i woskowy nośnik |
| CN102046812A (zh) | 2008-04-02 | 2011-05-04 | 赛特克罗公司 | 用于维生素d缺乏症和相关障碍的方法、组合物、用途和试剂盒 |
| PT2552484T (pt) | 2010-03-29 | 2020-04-03 | Opko Ireland Global Holdings Ltd | Métodos e composições para redução dos níveis de parafróides |
| KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 ｄ 방출 제형 |
| US10220047B2 (en) | 2014-08-07 | 2019-03-05 | Opko Ireland Global Holdings, Ltd. | Adjunctive therapy with 25-hydroxyvitamin D and articles therefor |
| MY198547A (en) | 2016-03-28 | 2023-09-04 | Opko Ireland Global Holdings Ltd | Methods of vitamin d treatment |
| CN108445237A (zh) * | 2018-06-20 | 2018-08-24 | 广州市康润生物科技有限公司 | 一种pth快速免疫检测系统的新用途 |
| CN112349362B (zh) * | 2019-08-08 | 2025-06-20 | 深圳先进技术研究院 | 一种甲状旁腺激素分泌监测与调控系统 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4369138A (en) | 1980-07-15 | 1983-01-18 | Immuno Nuclear Corporation | Parathyroid radioimmunoassay |
| US4423037A (en) | 1982-05-13 | 1983-12-27 | The General Hospital Corporation | Inhibitors of peptide hormone action |
| US4508828A (en) | 1983-03-21 | 1985-04-02 | Immuno Nuclear Corporation | Bioassay of parathyroid hormone |
| FR2550204B1 (fr) | 1983-08-05 | 1987-11-13 | Toyo Jozo Kk | Derives peptidiques de (nle8,nle1b, tyr34)-h-pth |
| DE3347548A1 (de) | 1983-12-30 | 1985-07-11 | Rolf Dieter Prof.Dr. 3004 Isernhagen Hesch | Mittel und verfahren zur spezifischen immunologischen bestimmung des c-terminalen parathormonfragments 68-84 |
| DE3935738A1 (de) | 1989-10-27 | 1991-05-08 | Forssmann Wolf Georg | Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff |
| US5317010A (en) | 1991-10-10 | 1994-05-31 | Peter K. T. Pang | Parathyroid hormone analogues substituted at AA 25, 26, 27, and use in osteoporosis treatment |
| WO1994003201A1 (en) | 1992-08-05 | 1994-02-17 | Hilliker Sandra R | Parathyroid hormone fragments and analogs |
| DE4434551A1 (de) | 1994-09-28 | 1996-04-04 | Forssmann Wolf Georg Prof Dr D | Peptide aus der Sequenz des hPTH (1-37) |
| US6689566B1 (en) | 1999-01-14 | 2004-02-10 | Scantibodies Laboratory, Inc. | Methods, kits, and antibodies for detecting parathyroid hormone |
| US6923968B2 (en) | 2000-08-10 | 2005-08-02 | Scantibodies Laboratory, Inc. | Cyclase inhibiting parathyroid hormone antagonists or modulators and osteoporosis |
| US6524788B1 (en) | 2001-11-02 | 2003-02-25 | Thomas L. Cantor | Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism |
-
2002
- 2002-11-01 US US10/286,465 patent/US7056655B2/en not_active Expired - Fee Related
- 2002-11-04 CA CA002465862A patent/CA2465862A1/en not_active Abandoned
- 2002-11-04 WO PCT/US2002/035516 patent/WO2003039572A1/en not_active Ceased
- 2002-11-04 JP JP2003541863A patent/JP2005513419A/ja active Pending
- 2002-11-04 EP EP02776462A patent/EP1448217A4/en not_active Withdrawn
-
2006
- 2006-03-17 US US11/377,980 patent/US20060223119A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005513419A5 (https=) | ||
| Horiuchi et al. | Similarity of synthetic peptide from human tumor to parathyroid hormone in vivo and in vitro | |
| Lane et al. | Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. | |
| AU2003207512B2 (en) | Treatment of bone disorders with skeletal anabolic drugs | |
| Henriksen et al. | Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2 | |
| Sharpe et al. | Alendronate: an update of its use in osteoporosis | |
| AU599905B2 (en) | Method of increasing bone mass | |
| JP7049412B2 (ja) | 骨折リスクの低減におけるＰＴＨｒＰアナログの使用 | |
| JP2018508489A (ja) | アルカリホスファターゼ欠損を有する被験者を治療する方法 | |
| JP2009508820A (ja) | 副甲状腺ホルモンアナログおよび使用法 | |
| NZ507056A (en) | Use of PTH in increasing bone toughness and stiffness and reducing fractures | |
| Pennisi et al. | Glucocorticoid-induced osteoporosis and its treatment | |
| JP2007518800A (ja) | Ｐｔｈ受容体アゴニストによる骨転移の治療 | |
| LERMAN et al. | Parathyroid hormone and the hypercalcemia of immobilization | |
| Nagasaki et al. | Invitro and invivo antagonists against parathyroid hormone-related protein | |
| Devogelaer et al. | Biologicals in osteoporosis: teriparatide and parathyroid hormone in women and men | |
| Cosman | Teriparatide and abaloparatide treatment for osteoporosis | |
| JP2008513459A (ja) | 骨同化物質を用いた骨疾患の治療方法 | |
| WO2018189674A1 (en) | Prevention of bone and mineral disorders by restoring calcium and phosphate homeostasis in patients suffering from chronic kidney disease. | |
| Oyoo et al. | Osteoporosis--From hormonal replacement therapy to bisphosphonates and beyond: A review | |
| Marsh et al. | Alternatives to HRT in prevention and treatment | |
| Davie et al. | Anomalous Rise of Serum Osteocalcin Following Desf errioxamine Treatment in Aluminium Intoxication | |
| Fall | The Osteoporosis Care Gap | |
| Owens | Dose-dependent effects of salmon calcitonin on bone turnover in ovariectomized rats | |
| Berger et al. | Exogenous calcitonin (CT)—a probe for the state of mineral metabolism in idiopathic recurrent calcium urolithiasis (RCU) |